期刊文献+

蜂针对佐剂性大鼠类风湿性关节炎IL-15影响的研究

Effect of Bee Venom Therapy on Interleulin-15 in Rats with Adjuvant-induced Rheumatoid Arthritis
原文传递
导出
摘要 目的:观察蜂针对佐剂性大鼠类风湿性关节炎(RA)白细胞介素-15(IL-15)的影响。方法:将120只大鼠随机分为蜂针治疗组、激素治疗组、病理模型组、正常对照组,每组各30只。正常对照组不造模,其余3组采用Freund氏完全佐剂制造大鼠关节炎模型。蜂针治疗组:取肾俞、足三里、命门、大椎穴,用镊子轻轻捏住蜜蜂的腰部,将其尾部对准穴位,让其自然蛰入穴位并留针10 min。均治疗21天,用ELISA法检测外周血IL-15水平。结果:与正常对照组比较,病理模型组、激素治疗组、蜂针治疗组IL-15水平均升高,差异均有显著性意义(P<0.05);与病理模型组比较,激素治疗组、蜂针治疗组IL-15水平明显下降,差异均有显著性意义(P<0.05);与激素治疗组比较,蜂针治疗组IL-15水平略高,差异有显著性意义(P<0.05)。结论:蜂针治疗RA可以有效降低IL-15水平,从而有效缓解RA病情。 Objective: To observe the effect of bee venom therapy on interleukin-15(IL-15)in rats with adjuvant-induced rheumatoid arthritis. Methods. One hundred and twenty rats were equally randomized into bee venom group, hormone group, model group and normal group. Except the normal group, rats in the other three groups were given Freund's complete adjuvant to induce rheumatoid arthritis. Bee venom group was stung by the bees for 10 min on acupoints of Shenshu, Zusanli, Mingmen and Dazhui. After treatment, enzyme-linked immunosorbent assay(ELISA) was used for the detection of peripheral blood IL-15 level. Results: In comparison with normal group, IL-15 was increased in model group, bee venom group and hormone group(P 〈0.05). After treatment, IL-15 was decreased in bee venom group and hormone group(P〈0.05 compared with the model group), and bee venom group had higher IL-15 than hormone group (P 〈0.05). Conclusion: Bee venom therapy is effective for the treatment of adjuvant-induced rheumatoid arthritis bv decreasinq IL-15 in rats.
出处 《新中医》 CAS 2014年第2期197-199,共3页 New Chinese Medicine
基金 广东省中医药局课题(编号:2010226)
关键词 类风湿性关节炎(RA) 蜂针 IL-15 动物模型 Rheumatoid arthritis Bee venom therapy., Interleukin-15 Animal models
  • 相关文献

参考文献11

  • 1张义浜,刘志敏,熊凌霜.类风湿关节炎发病机制及其治疗方法研究进展[J].细胞与分子免疫学杂志,2005,21(B03):88-90. 被引量:66
  • 2Foumier, Catherine. Where do T ceils stand in rheumatoid arthritis?[J]. Joint Bone Spine, 2005, 72 (6): 527-532.
  • 3Morris JC, Janik JE, White JD, et al. Preclinical and phase I clinical trial of blockade of IL-15 using Mikβ1 monoclonal antibody in T cell large granular lymphocyte leukemia[J]. Proceedings of The National Academy of Scienc es of The United States of America, 2006, 103(2): 401-406.
  • 4宛春甫,刘玉华,李志华,柳顺锁,孟庆云.类风湿性关节炎的发病因素研究进展[J].疑难病杂志,2005,4(5):317-319. 被引量:21
  • 5Oppenheimer-Marks N, Brezinschek RI, Mo- hamadzadeh M, et ai. Interleukin-15 is produced by endothelial cells and increases the transendothelial mi- gration of T cells invitro and in the SCID mouse-human rheumatoid arthritis model in vivo IJ]. J Clinlvest, 2004, 101(6): 1261-1272.
  • 6刘洪,廖琦,郝亮.IL-15在兔膝创伤性关节炎模型中的表达研究[J].南昌大学学报(医学版),2010,50(1):9-12. 被引量:1
  • 7Mclnnes IB, al-Mughales J, Field M, et al. The role of interleukin-15 in T cell migration and activation in rheumatoid arthritis[J]. Nat Med, 2000, 2(2).. 175- 182.
  • 8Mclnnes IB, Leung BP, Sturrock RD, et al. Inter- leukin-15 mediates T Cell-dependent regulation of tu- mor necrosis factor-alpha production in rheumatoid arthritis[J]. Nat Med, 2002, 3(2): 189-195.
  • 9Yan Wu, Lingxin Zhu, Hongxia Wei, et al. Regulation of matrix metalloproteinases, tissuce inhibitor of matrix metallopoteinase-1, and extracellular metallopro- teinase inducer by interleukin-17 in human periodontal ligament fibroblasts [J]. J Endod, 2013, 39 (1): 62-67.
  • 10张含玉.类风湿性关节炎患者IL-1、IL-15的水平变化及意义[J].实用预防医学,2008,15(3):870-871. 被引量:3

二级参考文献71

  • 1卿之驹,秦立新,蒋春洁.类风湿性关节炎患者血清细胞因子水平变化的临床意义[J].中南大学学报(医学版),2004,29(3):359-360. 被引量:3
  • 2许洪平,熊海涛,陈允旺,茅志坚,伏东宁,李伟洁,臧玉珍,赵剑青,房柱.蜂针疗法配合中药治疗类风湿性关节炎近、远期疗效观察[J].蜜蜂杂志,1996,16(4):3-4. 被引量:2
  • 3恭齐铭.蜂毒治疗关节炎[J].中国养蜂,1996,47(3):33-33. 被引量:1
  • 4Zvaifler Nathan J.类风湿性关节炎发病机理[A]..风湿病学新进展[C].四川科技出版社,..
  • 5Yoshizaki K, Nishimoto N, Mihara M, et al. Therapy of rheumatoid arthritis by blocking Il-6 signal transduction with a humanized anti-IL-6 receptor antibody[J]. Springer Semin Immunopathol, 1998, 20(2): 247-259.
  • 6Schett G, Tohidast-Akrad M, Smolen JS, et al. Activation, differential localization, and regulation of the stress-activated protein kinases, extracellular signal-regulated kinase, c-JUN N-terminal kinase, and p38 mitogen-activated protein kinase, in synovial tissue and cells in rheumatoid arthritis[J]. Arthritis Rheum, 2000, 43(9): 2501-2512.
  • 7Han Z, Boyle DL, Chang L, et al. c-Jun N-terminal kinase is required for metalloproteinase expression and joint destruction in inflammatory arthritis[J]. J Clin Invest, 2001, 108(1): 73-81.
  • 8Shiozawa S, Shimizu K, Tanaka K, et al. Studies on the contribution of c-fos/AP-1 to arthritic joint destruction[J]. J Clin Invest, 1997, 99(6): 1210-1216.
  • 9Vanderbark AA, Morgan E, Bartholomew R, et al. TCR peptide therapy in human autoimmune disease[J]. Neurochem Res, 2001, 26(6): 713-773.
  • 10Gracie JA, Forsey RJ, Chan WL, et al. A proinflammatory role for IL-18 in rheumatoid arthritis[J]. J Clin Invest, 1999, 104(10): 1393-1401.

共引文献88

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部